Sandbox:Ascites DD: Difference between revisions

Jump to navigation Jump to search
 
Line 304: Line 304:
!Ascitic fluid:
!Ascitic fluid:
* Exudative Vs Transudative
* Exudative Vs Transudative
* Colour
* General appearance
!CBC
!CBC
|-
|-
Line 382: Line 382:
| style="background: #F5F5F5; padding: 5px;" |<1.1
| style="background: #F5F5F5; padding: 5px;" |<1.1
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Transudate
* Clear
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 416: Line 418:
| style="background: #F5F5F5; padding: 5px;" |<1.1
| style="background: #F5F5F5; padding: 5px;" |<1.1
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
*
*Exudate
*Turbid or cloudy
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |Amylase level >100 units/L in the ascitic fluid
| style="background: #F5F5F5; padding: 5px;" |Amylase level >100 units/L in the ascitic fluid
Line 433: Line 436:
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |≥1.1
| style="background: #F5F5F5; padding: 5px;" |≥1.1
| style="background: #F5F5F5; padding: 5px;" |
| rowspan="2" style="background: #F5F5F5; padding: 5px;" |
* Transudate
* Clear
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 449: Line 454:
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | ≥1.1
| style="background: #F5F5F5; padding: 5px;" | ≥1.1
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 467: Line 471:
| style="background: #F5F5F5; padding: 5px;" |<1.1
| style="background: #F5F5F5; padding: 5px;" |<1.1
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Transudate
*
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 516: Line 522:
| style="background: #F5F5F5; padding: 5px;" | ≥1.1 or <1.1
| style="background: #F5F5F5; padding: 5px;" | ≥1.1 or <1.1
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Exudate
* Turbid
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 532: Line 540:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Transudate
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |Low TSH level  
| style="background: #F5F5F5; padding: 5px;" |Low TSH level  
Line 548: Line 557:
| style="background: #F5F5F5; padding: 5px;" | ≥1.1
| style="background: #F5F5F5; padding: 5px;" | ≥1.1
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Transudate
* Bloody
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |Tumor markers for determination of the cancer type
| style="background: #F5F5F5; padding: 5px;" |Tumor markers for determination of the cancer type
|}
|}

Latest revision as of 17:14, 30 November 2017

Genes

TMEM67 TTC21B WDR19 ZNF423 CEP164 ANKS6 INPP5E TMEM216 AHI1 NPHP1 CEP290 RPGRIP1L ARL13B CC2D2A OFD1 TTC21B KIF7 TCTN1 CEP41 TMEM138 C5orf42 TCTN3 ZNF423 TMEM231 TCTN2 BBS1 BBS2 ARL6 BBS4 BBS5 MKKS BBS7 TTC8 BBS9 BBS10 TRIM32 BBS12 MKS1 CEP290 MKS1 CC2D2A NPHP3 B9D1 B9D2 IFT122 EVC EVC2 IFT80 OFD1 PKD1 PKD2 Timp1 CALHM1 GST01 PAX1P1 PLD3 TOMM40 UNC5C SLC24A4 PTK2B ZCWPW1 CELF1 FERMT2 CASS4 INPP5D NME8 UBQLN1 GSD 1 GSD type 1a GSD type 1b FAM111A CHD7 G744S AIRE

=Chromosome 1

p-arm The following are some of the genes located on p-arm (short arm) of human chromosome 1:

  • AADACL3
  • AADACL4
  • ACADM
  • ACTL8
  • AMPD2
  • ATXN7L2
  • AZIN2
  • BCAS2
  • C1orf103
  • C1orf109
  • C1orf123
  • CASZ1
  • CMPK
  • COL11A1
  • CPT2
  • CRYZ
  • CSDE1
  • DBT
  • DCLRE1B
  • DEPDC1
  • DIRAS3
  • DPH5
  • ESPN
  • EVI5
  • EXTL1
  • EXTL2
  • FAM46B
  • FAM46C
  • FAM76A
  • FBXO2
  • FPGT
  • GALE
  • GBP2
  • GJB3
  • GNL2
  • HES2
  • HES3
  • HMGCL
  • HAO2
  • HMGCS2
  • HP1BP3
  • IFI6
  • INTS11
  • KCNQ4
  • KIF1B
  • L1TD1
  • LRRC39
  • LRRC40
  • LRRC41
  • LRRC8D
  • MAN1A2
  • MEAF
  • MECR
  • MFAP2
  • MFN2
  • MFSD2
  • MIR6079
  • MMEL1
  • MTFR1L
  • MTHFR
  • MUL1
  • MUTYH
  • NBPF3
  • NGF
  • NOL9
  • OLFML3
  • OMA1
  • OVGP1
  • PARK7
  • PINK1
  • PLOD1
  • PRMT6
  • PSRC1
  • RAD54
  • RCC2
  • RHBDL2
  • RLF
  • RNF220
  • SDC3
  • SGIP1
  • SH3BGRL3
  • SPSB1
  • SYCP1
  • SZT2
  • TACSTD2
  • TCEB3
  • TMCO4
  • TMEM48
  • TMEM50A
  • TMEM59
  • TMEM69
  • TMEM222
  • TOE1
  • TRAPPC3
  • TRIT1
  • TSHB
  • TTC39A
  • UBR4
  • UROD
  • USP48
  • VPS13D
  • WARS2
  • ZCCHC17
  • ZMYM1
  • ZNF436
  • ZZZ3

q arm

  • AHCTF1
  • ANGPTL1
  • ARID4B
  • ASPM
  • C1orf21
  • C1orf35
  • C1orf49
  • C1orf74
  • C1orf106
  • CD5L
  • CENPL
  • CHTOP
  • CNIH4
  • CNST
  • CREG1
  • CRP
  • CSRP1
  • DDX59
  • DPT
  • DNAH14
  • EDEM3
  • F5
  • FAM20B
  • FAM63A
  • FAM78B
  • FAM129A
  • FBXO28
  • FCMR
  • FMO3
  • GBA
  • GBAP1
  • GLC1A
  • GON4L
  • HEATR1
  • HFE2
  • HIST2H2AB
  • HIST2H2BF
  • HIST2H3PS2
  • HIST3H2A
  • HIST3H2BB
  • HPC1
  • INTS3
  • IRF6
  • LEFTY1
  • LMNA
  • LYPLAL1
  • MIR194-1
  • MIR5008
  • MPC2
  • MOSC1
  • MOSC2
  • MPZ
  • MSTO1
  • NAV1
  • NBPF1
  • NOC2L
  • NUCKS1
  • NVL
  • OLFML2B
  • OPTC
  • OTUD7B
  • PGDB5
  • PI4KB
  • PIP5K1A
  • PPOX
  • PRR9
  • PSEN2
  • RABIF
  • RN5S1
  • SCAMP3
  • SDHB
  • SLC50A1
  • SMCP
  • SMG7
  • SPRR1A
  • SPRR1B
  • SPRR2A
  • SPRTN
  • TARBP1
  • TBCE
  • THBS3
  • TMCO1
  • TMEM9
  • TMEM63A
  • TNNT2
  • TOR1AIP1
  • UAP1
  • USH2A
  • VPS45
  • VPS72
  • YY1AP1
  • ZBED6
  • ZC3H11A
  • ZNF687
  • ZNF648
  • ZNF695

Preferred Table

Diseases History and Symptoms Physical Examination Laboratory Findings Other Findings
Fever Icterus Abdominal pain Peripheral edema Chest pain Jugular vein distension Hepatomegaly Skin rash Edema Spider angiomata Serum to ascites albumin gradient (SAAG) Ascitic fluid:
  • Exudative Vs Transudative
  • General appearance
CBC
Hepatic causes Cirrhosis - + - - - + - - - +  ≥1.1
  • Transudate
  • Opalescent
Budd chiari syndrome - + - - - - + - - +
Acute liver failure + + +/- + - - + +/- + -
Alcoholic hepatitis - - - - - - + - - -
GI causes Whipple disease + - + - - - - - - - <1.1
  • Transudate
  • Clear
Peritonitis + - + - - - - - - -  ≥1.1 or <1.1
  • Exudate
  • Turbid or cloudy
Pancreatitis + (Severe pancreatitis) - - - - - - + (In rare cases) - - <1.1
  • Exudate
  • Turbid or cloudy
Amylase level >100 units/L in the ascitic fluid
Cardiac causes CHF - - - + + + + (In Rt heart failure) - + - ≥1.1
  • Transudate
  • Clear
Pericarditis + - - - + + + - - -  ≥1.1
Renal cause Nephrotic syndrome - - - + - - - - + - <1.1
  • Transudate
Other causes Sarcoidosis + - - - + - + + - -
SLE + - - - - - - + - -
TB + - - - + - - + (In Cutaneous TB) - -  ≥1.1 or <1.1
  • Exudate
  • Turbid
Hypothyroidism - + (Myxedematous edema) - - - + (Myxedematous edema) -
  • Transudate
Low TSH level
Cancer - +/- +/- - +/-  ≥1.1
  • Transudate
  • Bloody
Tumor markers for determination of the cancer type